Pruritus News and Research

RSS
Warning against colloids in fluid resuscitation

Warning against colloids in fluid resuscitation

Severe egg allergy treatment shows promise

Severe egg allergy treatment shows promise

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Shampoo effective for pruritus relief in dogs

Shampoo effective for pruritus relief in dogs

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Positive preliminary results from Feraheme phase III study on iron deficiency anemia

Positive preliminary results from Feraheme phase III study on iron deficiency anemia

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

EC grants marketing authorization for AMAG's ferumoxytol to treat IDA

EC grants marketing authorization for AMAG's ferumoxytol to treat IDA

Positive results from Cara’s CR845 Phase II study on acute post-operative pain

Positive results from Cara’s CR845 Phase II study on acute post-operative pain

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Chinese sFDA approves Baxter's ADVATE to treat hemophilia A

Chinese sFDA approves Baxter's ADVATE to treat hemophilia A

NEJM publishes results from Celgene’s REVLIMID phase III studies on MM

NEJM publishes results from Celgene’s REVLIMID phase III studies on MM

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

Otsuka announces results from aripiprazole Phase 3 trial on schizophrenia

EMA CHMP recommends approval of AMAG’s ferumoxytol

EMA CHMP recommends approval of AMAG’s ferumoxytol

Vanda acquires license from Lilly to develop and commercialize NK-1R antagonist

Vanda acquires license from Lilly to develop and commercialize NK-1R antagonist

Merck announces data from ZOSTAVAX Phase III study on shingles

Merck announces data from ZOSTAVAX Phase III study on shingles

Galeterone safe, effective for patients with CRPC

Galeterone safe, effective for patients with CRPC

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA

Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis

Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis